NIH initiates HIV prevention trial of long-acting injectable medication in sexually active women
The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study in southern and...
Portugal researcher to create 3D cancer disease models
The Institution of Engineering and Technology (IET) in the UK has awarded a prize fund to a Portuguese researcher for the creation of reliable...
FDA grants orphan drug status to Shire’s UC treatment SHP647
The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody, SHP647, for...
Cancer Genetics and ICON to reduce cancer mortality rate in India
US-based Cancer Genetics (CGI) has collaborated with the Indian Cooperative Oncology Network (ICON) to minimise cancer mortality rates by optimising clinical outcomes for patients...
Lilly’s Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
Eli Lilly and Company announced that the U.S. FDA has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic...
Sanofi Expects $120 Million Hit As Dengue Vaccine Hits Major Snag
Use of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it can...
Kyowa Hakko Kirin Submits the Partial Change Approval Application of Mogamulizumab in Japan
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and CEO: Nobuo Hanai; announces the submission of a supplemental application to remove the requirement for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...